The Global Antifungal agents market is anticipated to grow at a CAGR of 3.72% between 2018 and 2026. The antifungal agents are fungistatic in nature and are used to prevent and treat mycoses such as candidiasis, ringworm, etc. These are essentially the drugs which help in detecting and eliminating fungal pathogens from the foreign body with less toxic side effects to the body. The Antifungal agents market is primarily driven by the following factors:

• Poor hygiene habits
• Development of drug resistance
• Healthcare policies and programs by government

To know more about this report, request a free sample copy.

The important driver increasing growth in the global antifungal agents market is the development of drug resistance. The growing concern amongst the population regarding health issue has positively influenced the growth in the medical sector. The infections like yeasts and pathogenic fungi can invade and overtake the human body. Hence, there is an increasing demand for antifungal drugs in the market.

The applications of antifungal agents market can be found extensively for various purposes. Topical drugs are those medications which are directly applied to the skin or the affected portion of the body. These come in wide forms like pastes, ointments, powder, and others. Most of the topical drugs have systematic effects because they are first absorbed by the skin and are then circulated. Oral antifungal agents include fluconazole, terbinafine, itraconazole, and ketoconazole. These oral antifungal agents are reserved for serious infection for which topical antifungal agents are ineffective or inappropriate. Most of the oral Antifungal agents are the medicines which are available only through prescription and are available in dosage forms such as capsules, suspensions, and tablets.

Alternate treatment options and regulatory atmosphere are the major factors hindering the growth of the antifungal agents market. There are various types of fungal infections for which patients take home remedies or the herbal treatments. This is restricting the growth of the antifungal agents market. Such alternative treatments are the types of the conventional drugs which are the major restricting factors of the market. At present, a large portion of the antifungal medications are outside value control, and there is a wide mystifying distinction between brands in terms of their retail costs.

The global antifungal agents market segments include drug types, therapeutic indications, types, and applications.

Drug Types are segmented into:

• Systemic azoles
• Topical azoles
• Systemic polyenes
• Topical polyenes
• Systemic echinocandins
• Systemic antimetabolics
• Other systemic
• Other topical
• Other drugs types

Therapeutic Indications are segmented into:

• Aspergillosis market
• Dermatophytosis market
• Candidiasis market
• Others market

Types are segmented into:

• Prescription
• Over the counter (OTC)

Applications are segmented into:

• Topical antifungal agents market
• Oral drugs market

This report covers the present market conditions and the growth prospects of the global antifungal agents market for 2018-2026 and considered the revenue generated through the sales of antifungal agents for drug types, therapeutic indications, and applications in order to calculate the market size by considering 2017 as the base year.

Geographically, the global antifungal agents market has been segmented on the basis of four major regions, which include:

• Antifungal Agents North America Market – The U.S. & Canada
• Antifungal Agents Asia-Pacific Market – India, China, Japan, South Korea, Taiwan & ROAPAC
• Antifungal Agents Europe Market – The United Kingdom, France, Germany, Spain, Italy, Benelux, Scandinavia, Austria and Rest of Europe
• Latin America- Brazil, Mexico, Argentina, Chili & ROLA (Rest of Latin America)
• Rest of World- Middle East and North Africa & Rest of Africa

The Antifungal agents market in North America is expected to hold the largest share by 2026 owing to the huge investments made in drug productions along with the government initiatives related to fungal infections and their treatment. Endemic fungal infection follows distinct geographic distributions that are determined by the condition of the soil and climate, which would be optimal for the fungi’s growth. North America is home to 3 of the major endemic mycoses type: histoplasmosis, blastomycosis, and coccidioidomycosis. Although, the prevalence of these varies by region. On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the antifungal agents market. In India, the growing healthcare industry is boosting the antifungal agents market. Fungal infections are increasing year by year in China because of the application of immunosuppressant and wide-spectrum antibiotics. In Japan, increase in a number of fungal diseases is boosting the antifungal agent market, as antifungal agents are used to treat fungal infections.

The antifungal agents market is segmented based on drug types which are sub-divided into systemic azoles, topical azoles, systemic polyenes, topical polyenes, systemic echinocandins, systemic antimetabolics, other systemic, other topical, and other drugs types. It is also segmented on the basis of Therapeutic indications which are sub-divided into Aspergillosis, Dermatophytosis, Candidiasis, and others. On the basis of types, the market is categorized into Prescription and OTC. Echinocandins are characterized by their capability to prevent synthesis of a key component of the fungal cell wall. Azole antifungals are characterized by the capability to prevent ergosterol synthesis in fungal membranes. Aspergillosis refers to an infection that is caused by Aspergillus, i.e. a type of fungus. Dermatophytosis refers to a group of fungi that enter and grow in the dead keratin of hair, skin, and nails. Candidiasis refers to a fungal infection due to any type of yeast (Candida).

The major market players in the global antifungal agents market are:

• Abbott Laboratories
• Baxter
• Bayer Healthcare
• Johnson & Johnson
• Pfizer

Company Profiles covers analysis of important players.

Abbott Laboratories was founded by Dr Wallace Calvin Abbott in 1888.  Abbott has experience and knowledge for more than 125 years. Abbott has products for all, from newborns to ageing adults, from diagnostics to pharmaceutical therapy and medical care. Another company, Pfizer, is an American global pharmaceutical company found in the year 1849. It is headquartered in New York City and comes in the list of the world’s largest pharmaceutical companies.

Key Findings of the Global Antifungal agents market:

• Tropical drugs market is the emerging application
• Aspergillosis therapeutic indication is leading the market